Concept information
Preferred term
Metaproterenol
Type
-
mesh:Descriptor
Definition
- A beta-2 adrenergic agonist used in the treatment of ASTHMA and BRONCHIAL SPASM.
Broader concept
Narrower concepts
Entry terms
- 1,3-Benzenediol, 5-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-
- 53QOG569E0
- 586-06-1 (Metaproterenol)
- GJ20H50YF0
- Orciprenaline
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Pharmacological Action(s)
In other languages
-
French
-
1,3-Benzenediol, 5-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-
-
53QOG569E0
-
586-06-1 (Metaproterenol)
-
GJ20H50YF0
-
Métaprotérénol
URI
http://data.loterre.fr/ark:/67375/JVR-RW4QKDXJ-X
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}